Lv1
40 积分 2025-12-01 加入
HFpEF and MASLD: converging mechanisms and clinical implications
14天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
15天前
已完结
Association of Subclinical Heart Maladaptation With the Pooled Cohort Equations to Prevent Heart Failure Risk Score for Incident Heart Failure
17天前
已完结
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review
1个月前
已完结
Impact of Metabolic Dysfunction–associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure
2个月前
已完结
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
2个月前
已完结
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
2个月前
已完结
International Society for Heart and Lung Transplantation Consensus Statement for the Selection and Management of Patients With Left Ventricular Assist Devices
2个月前
已关闭
中国左心室辅助装置候选者术前评估与管理专家共识(2023年)
2个月前
已完结
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
2个月前
已完结
皖公网安备34019202002308
